Plain-English translation of NCT06932263 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help adults whose asthma is not well controlled even though they are already using medium-to-high dose inhaler steroids. The medication is given as an injection under the skin. Researchers want to find the best dose and confirm it is safe and effective for this group of patients.
Many people with asthma continue to have symptoms and flare-ups despite using standard steroid inhalers. This medication targets a specific part of the immune system involved in asthma, and this trial aims to see if it can reduce these breakdowns and help patients breathe better.
You likely qualify if…
You likely don't qualify if…
You would receive either the new medication or a placebo (inactive injection) given as a shot under the skin at regular clinic visits over several months. You would keep a daily diary about your asthma symptoms and attend multiple study visits for check-ups, breathing tests, and blood work. The study compares different doses of the medication to see which works best and causes the fewest side effects.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States